Abstract:Alkylating agents (AAs) that are commonly used for cancer therapy cause great damage to the ovary. Pyrroloquinoline-quinine (PQQ), which was initially identified as a redox cofactor for bacterial dehydrogenases, has been demonstrated to benefit the fertility of females. The aim of this study was to investigate whether PQQ dietary supplementation plays a protective role against alkylating agent-induced ovarian dysfunction. A single dose of busulphan (20 mg/kg) and cyclophosphamide (CTX, 120 mg/kg) were used to establish a mouse model of ovarian dysfunction. Feed containing PQQNa 2 (5 mg/kg) was provided starting 1 week before the establishment of the mouse model until the date of sacrifice. One month later, estrous cycle period of mice were examined and recorded for consecutive 30 days. Three months later, some mice were mated with fertile male mice for fertility test. The remaining mice were sacrificed to collect serum samples and ovaries. One day before sacrifice, some mice received a single injection of BrdU to label proliferating cells. Serum samples were used for test hormonal levels. Ovaries were weighted and used to detect follicle counts, cell proliferation, cell apoptosis and cell senescence. In addition, the levels of inflammation, oxidative damage and Pgc1α expression were detected in ovaries. Results showed that PQQ treatment increased the ovarian weight and size, partially normalized the disrupted estrous cycle period and prevented the loss of follicles of mice treated with AAs. More importantly, we found that PQQ treatment significantly increased the pregnancy rate and litter size per delivery of mice treated with AAs. The protective effects of PQQ appeared to be directly mediated by promoting cell proliferation of granulosa, and inhibiting cell apoptosis of granulosa and cell senescence of ovarian stromal cells. The underlying mechanisms may attribute to the anti-oxidative stress, anti-inflammation and pro-mitochondria biogenesis effects of PQQ.Our study highlights the therapeutic potential of PQQ against ovarian dysfunction caused by alkylating agents.

Production and radioprotective effects of pyrroloquinoline quinone.

Production and Radioprotective Effects Of

The Preliminary Study in the Role of Pyrroloquinoline Quinine on the Γ-Ray Radiation Protection of Mice

Pyrroloquinoline Quinone Alleviates Mitochondria Damage in Radiation-Induced Lung Injury in a MOTS-c-Dependent Manner

Effect of Pyrroloquinoline Quinine on Anti-Oxidative Competence of AGS Cell Radiated by Γ-Ay

Effect of pyrroloquinoline quinone on free radical in rats with radiation-induced skin injury

Pyrroloquinoline quinone ameliorates liver injury in mice induced by cyclophosphamide

A subchronic oral toxicity study on pyrroloquinoline quinone (PQQ) disodium salt in rats

Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway

[Effects of Pyrroloquinoline Quinine on Oxidative Stress-Induced Apoptosis of Schwann Cells and Its Mechanism].

Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits: PQQ: Human health impacts and benefits

PQQ Dietary Supplementation Prevents Alkylating Agent-Induced Ovarian Dysfunction in Mice

Protective effect of pyrroloquinoline quinine on ultraviolet A irradiation-induced human dermal fibroblast senescence in vitro proceeds via the anti-apoptotic sirtuin 1/nuclear factor-derived erythroid 2-related factor 2/heme oxygenase 1 pathway

Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts

Protective effect and mechanism of pyrroloquinoline quinine (PQQ) against UVA induced human skin fibroblasts aging

Protection of Pyrroloquinoline Quinone Against Methylmercury-Induced Neurotoxicity Via Reducing Oxidative Stress.

Purification of Pyrroloquinoline Quinone and Its Therapeutic Effect on Lead Poisoned Mice

Effects of Orally Administered Pyrroloquinoline Quinone Disodium Salt on Dry Skin Conditions in Mice and Healthy Female Subjects

Pyrroloquinoline Quinone Prevents MK-801-induced Stereotypical Behavior and Cognitive Deficits in Mice

Pyrroloquinoline Quinone Against Glutamate-Induced Neurotoxicity in Cultured Neural Stem and Progenitor Cells

Pyrroloquinoline Quinone-Conferred Neuroprotection in Rotenone Models of Parkinson'S Disease